Giovanni Musci

Dr. Giovanni Musci

Dipartimento di Bioscienze e Territorio, Università del Molise, Pesche (IS), Italy
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
IDIvana De Domenico
Ivana De Domenico
DWDiane McVey Ward
Diane McVey Ward
Maria Carmela Bonaccorsi Di PattiMaria Carmela Bonaccorsi Di Patti
Maria Carmela Bonaccorsi Di Patti
SJSuh Young Jeong
Suh Young Jeong
SDSamuel David
Samuel David
JKJerry Kaplan
Jerry Kaplan
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 March 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
ANTIMO CUTONEANTIMO CUTONE
ANTIMO CUTONE
Luigi RosaLuigi Rosa
Luigi Rosa
Giusi IaniroGiusi Ianiro
Giusi Ianiro
MLMaria Stefania Lepanto
Maria Stefania Lepanto
Maria Carmela Bonaccorsi Di PattiMaria Carmela Bonaccorsi Di Patti
Maria Carmela Bonaccorsi Di Patti
Giovanni MusciGiovanni Musci
Giovanni Musci
Despite recent advances in cancer therapy, current treatments, including radiotherapy, chemotherapy, and immunotherapy, although beneficial, present attendant side effects and long-term sequelae, usually more or less affecting quality of life of the patients. Indeed, except for most of the immunotherapeutic agents, the complete lack of selectivity between normal and cancer cells for radio- and chemotherapy can make them potential antagonists of the host anti-cancer self-defense over time. Recently, the use of nutraceuticals as natural compounds corroborating anti-cancer standard therapy is emerging as a promising tool for their relative abundance, bioavailability, safety, low-cost effectiveness, and immuno-compatibility with the host. In this review, we outlined the anti-cancer properties of Lactoferrin (Lf), an iron-binding glycoprotein of the innate immune defense. Lf shows high bioavailability after oral administration, high selectivity toward cancer cells, and a wide range of molecular targets controlling tumor proliferation, survival, migration, invasion, and metastasization. Of note, Lf is able to promote or inhibit cell proliferation and migration depending on whether it acts upon normal or cancerous cells, respectively. Importantly, Lf administration is highly tolerated and does not present significant adverse effects. Moreover, Lf can prevent development or inhibit cancer growth by boosting adaptive immune response. Finally, Lf was recently found to be an ideal carrier for chemotherapeutics, even for the treatment of brain tumors due to its ability to cross the blood–brain barrier, thus globally appearing as a promising tool for cancer prevention and treatment, especially in combination therapies.

26 May 2014 in World Journal of Biological Chemistry
Verified
Journal Article
Open access
Giovanni MusciGiovanni Musci
Giovanni Musci
FPFabio Polticelli
Fabio Polticelli
Maria Carmela Bonaccorsi Di PattiMaria Carmela Bonaccorsi Di Patti
Maria Carmela Bonaccorsi Di Patti
Laparoscopic surgery is the main treatment method for patients with gastrointestinal malignant tumors. Although laparoscopic surgery is minimally invasive, its tool stimulation and pneumoperitoneum pressure often cause strong stress reactions in patients. On the other hand, gastrointestinal surgery can cause stronger pain in patients, compared to other surgeries. Transversus abdominis plane block (TAPB) can effectively inhibit the transmission of nerve impulses caused by surgical stimulation, alleviate patient pain, and thus alleviate stress reactions. Remazolam is an acting, safe, and effective sedative, which has little effect on hemodynamics and is suitable for most patients. TAPB combined with remazolam can reduce the dosage of total anesthetic drugs, reduce adverse reactions, reduce stress reactions, and facilitate the rapid postoperative recovery of patients.

Verified
Journal Article
Open access
PDF file
ANTIMO CUTONEANTIMO CUTONE
ANTIMO CUTONE
MLMaria Stefania Lepanto
Maria Stefania Lepanto
Luigi RosaLuigi Rosa
Luigi Rosa
MSMellani Jinnett Scotti
Mellani Jinnett Scotti
ARAlice Rossi
Alice Rossi
FBFrancesca Berlutti
Francesca Berlutti
Cystic fibrosis (CF) is a genetic disorder affecting several organs including airways. Bacterial infection, inflammation and iron dysbalance play a major role in the chronicity and severity of the lung pathology. The aim of this study was to investigate the effect of lactoferrin (Lf), a multifunctional iron-chelating glycoprotein of innate immunity, in a CF murine model of Pseudomonas aeruginosa chronic lung infection. To induce chronic lung infection, C57BL/6 mice, either cystic fibrosis transmembrane conductance regulator (CFTR)-deficient (Cftrtm1UNCTgN(FABPCFTR)#Jaw) or wild-type (WT), were intra-tracheally inoculated with multidrug-resistant MDR-RP73 P. aeruginosa embedded in agar beads. Treatments with aerosolized bovine Lf (bLf) or saline were started five minutes after infection and repeated daily for six days. Our results demonstrated that aerosolized bLf was effective in significantly reducing both pulmonary bacterial load and infiltrated leukocytes in infected CF mice. Furthermore, for the first time, we showed that bLf reduced pulmonary iron overload, in both WT and CF mice. In particular, at molecular level, a significant decrease of both the iron exporter ferroportin and iron storage ferritin, as well as luminal iron content was observed. Overall, bLf acts as a potent multi-targeting agent able to break the vicious cycle induced by P. aeruginosa, inflammation and iron dysbalance, thus mitigating the severity of CF-related pathology and sequelae.

3 May 2014 in BioMetals
Verified
Journal Article
Closed access
PDF file
ACAntimo Cutone
Antimo Cutone
AFAlessandra Frioni
Alessandra Frioni
FBFrancesca Berlutti
Francesca Berlutti
Piera ValentiPiera Valenti
Piera Valenti
Giovanni MusciGiovanni Musci
Giovanni Musci
Maria Carmela Bonaccorsi Di PattiMaria Carmela Bonaccorsi Di Patti
Maria Carmela Bonaccorsi Di Patti

16 February 2018 in BioMetals
Verified
Journal Article
Closed access
PDF file
Maria Carmela Bonaccorsi Di PattiMaria Carmela Bonaccorsi Di Patti
Maria Carmela Bonaccorsi Di Patti
ACAntimo Cutone
Antimo Cutone
FPFabio Polticelli
Fabio Polticelli
Luigi RosaLuigi Rosa
Luigi Rosa
MLMaria Stefania Lepanto
Maria Stefania Lepanto
Giovanni MusciGiovanni Musci
Giovanni Musci